SOV Therapeutics, Inc. — Form D
SOV Therapeutics, Inc. of MORRISVILLE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-19. The offering totals $1.0M, of which $200K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-02-19
- Form: D
- Accession: 0001484177-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $200K
- Remaining: $800K
- Minimum investment: $20K
- Investors: 4
- Date of first sale: 2010-02-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-138891
Issuer
- Name: SOV Therapeutics, Inc.
- CIK: 0001484177
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2009
- Address: 101 GUYMON COURT, MORRISVILLE, NC, 27560
- Phone: 919 601-2208
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Om Dhingra | Director | Raleigh, NC |
| Om Dhingra | Executive Officer | Raleigh, NC |
| Himanshu Shah | Director | Raleigh, NC |
| Arun Shukla | Director | Raleigh, NC |
| Arun Shukla | Executive Officer | Raleigh, NC |
| Satinder Sethi | Director | Raleigh, NC |
Other filings by this issuer (1)
More